© The Financial Times Ltd 2014 FT and 'Financial Times' are trademarks of The Financial Times Ltd.
As of Jul 29, 2014, the consensus forecast amongst 53 polled investment analysts covering GlaxoSmithKline plc advises investors to hold their position in the company. This has been the consensus forecast since the sentiment of investment analysts deteriorated on Feb 21, 2013. The previous consensus forecast advised that GlaxoSmithKline plc would outperform the market.
|Last year||3 months ago||2 months ago||4 weeks ago||Latest|
The 24 analysts offering 12 month price targets for
|Div growth (TTM)||+5.41%|
On Jul 23, 2014,
The next earnings announcement is expected on Oct 22, 2014. View Full Interim Financials
|Average growth rate||-6.24%|
|Average growth rate||-1.42%|
GlaxoSmithKline plc had 2nd quarter 2014 revenues of 5.56bn. This missed the 5.76bn consensus estimate of the 10 analysts following the company. This was 0.93% below the prior year's 2nd quarter results. View Full Interim Financials
|Average growth rate||-3.80%|
GlaxoSmithKline plc had revenues for the full year 2013 of 26.51bn. This was 0.28% above the prior year's results. View Full Annual Financials
|Average growth rate||-1.67%|